HLA, anti-DNA, and complement in myasthenia gravis

Area of Science:

• Immunogenetics
• Autoimmune Diseases
• Myasthenia Gravis Research

Background:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• Human Leukocyte Antigen (HLA) complex plays a crucial role in immune responses and autoimmune diseases.
• Previous studies suggest a link between specific HLA types and MG susceptibility.

Purpose of the Study:

• To investigate the association of HLA-A, -B, -C, and -D specificities in myasthenia gravis patients.
• To correlate HLA types with immunodeficiency markers, thymic disease, and other autoimmune conditions.
• To explore the relationship between HLA specificities and anti-acetylcholine receptor (anti-AChR) autoantibodies.

Main Methods:

• HLA typing (HLA-A, -B, -C, and -D) was performed on 27 myasthenia gravis patients.
• Analysis included assessment of immunodeficiency evidence, thymic disease, and associated autoimmune processes.
• Specific immune markers such as anti-DNA, C4, E. coli antibody titers, serum IgM, and isohemagglutinin titers were measured.

Main Results:

• A subset of 8 female patients showed an association with HLA-A1, -B8, and -DRW3, exhibiting higher anti-DNA, lower C4, and lower E. coli antibody titers.
• Another group of females (6 out of 10) commonly presented with HLA-CW4 (with or without BW35).
• No clear relationship was found between anti-acetylcholine receptor (anti-AChR) autoantibody levels or reduced serum IgM and isohemagglutinin titers with specific HLA types.

Conclusions:

• Specific HLA types, including HLA-A1, -B8, -DRW3, and -CW4, may be associated with phenomena accompanying myasthenia gravis.
• These HLA associations might be linked to secondary autoimmune processes or immunodeficiency rather than the primary pathogenesis of anti-AChR antibodies in MG.
• Further research is needed to elucidate the precise role of these HLA associations in the broader clinical picture of myasthenia gravis.